Associated Papers
CDK4/6 Inhibitors Suppress RB-Null Triple-Negative Breast Cancer by Inhibiting Mutant P53 Expression via RBM38 RNA-Binding Protein.
Zhang J et al.
Cancers, 2025
Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a.
Lucchesi CA et al.
Cancer Research, 2021
Serine 195 phosphorylation in the RNA-binding protein Rbm38 increases p63 expression by modulating Rbm38's interaction with the Ago2-miR203 complex.
Zhang Y et al.
The Journal of Biological Chemistry, 2019
Hypoxia-inducible factor 1 alpha is regulated by RBM38, a RNA-binding protein and a p53 family target, via mRNA translation.
Cho SJ et al.
Oncotarget, 2015
Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1.
Zhang M et al.
Genes & Development, 2013
Select a paper to view details